Close Menu

NEW YORK (GenomeWeb) - GenMark Diagnostics said today it has received 510(k) clearance from the US Food and Drug Administration for a panel assay to detect gram-negative bacteria in blood cultures.

The ePlex Blood Culture Identification Gram-Negative (BCID-GN) Panel detects 21 gram-negative bacteria, six resistance genes, and pan targets for gram-positive organisms and Candida, according to the firm's website. It completes GenMark's suite of multiplex panels to detect bloodstream infections that can cause sepsis, the firm said in a statement.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Jan
28
Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

Feb
05
Sponsored by
LGC

This webinar will provide a behind-the-scenes look at the collaborative development of a novel multiplex assay to speed detection of mosquito-borne illness in the clinical setting.